Ackman: Allergan Rules For Shareholder Meetings Too Onerous - Presented by: The Aol. On Network

Allergan Inc, trying to fend off a hostile takeover bid from Valeant Pharmaceuticals International Inc, has stacked the odds against a special shareholders meeting. Pershing Square Capital Management, which is led by Bill Ackman, is attempting to muster at least 25 percent support of Allergan shares to hold a special meeting that could replace most of the Botox anti-wrinkle injection maker's board, which has refused to negotiate with Valeant.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.50 0.17 ▼ 1.02%
PFE $ 34.75 0.31 ▲ 0.90%
AAPL $ 130.28 1.50 ▼ 1.14%
INTC $ 34.46 0.45 ▲ 1.32%
RAD $ 8.72 0.02 ▲ 0.23%
GE $ 27.27 0.36 ▼ 1.30%
NRF $ 18.14 0.05 ▲ 0.28%
BSX $ 18.27 unch

As of 5/29/2015, 04:15 PM

Latest News Headlines

View All Latest Headlines